Volume 11.27 | Jul 19

Cell Therapy News 11.27, July 19, 2010.
In this issue:  Science  |  Policy  |  Business  |  NIH  |  CBER  |  Regulatory  |  Events Subscribe  |  Unsubscribe


Unearthing King Tet: Key Protein Influences Stem Cell Fate
Researchers have discovered that a protein called Tet 1 helps stem cells renew themselves and stay pluripotent. [Press release from University of North Carolina at Chapel Hill School of Medicine discussing online prepublication in Nature]



After 40 Years, NIH-Supported Researchers Identify Possible New Treatment for Severe Vasculitis
Investigators have made a major advance in treating people with a severe form of vasculitis, anti-neutrophil cytoplasmic antibody-associated vasculitis. [Press release from the National Institutes of Health discussing online prepublication in the New England Journal of Medicine]

Small Molecule Boosts Production of Brain Cells, Protects New Cells from Dying
Researchers have found a compound that preserves newly created brain cells and boosts learning and memory in an animal study. [Press release from the University of Texas Southwestern Medical Center discussing online prepublication in Cell]

Scientists Develop New Way to Grow Adult Stem Cells in Culture
Researchers have found that growing muscle stem cells on a specially developed synthetic matrix that mimics the elasticity of real muscle allows them to maintain their self-renewing properties. [Press release from the Stanford University School of Medicine discussing online prepublication in Science]

Investigators Identify Genetic Cause of Kidney Disease
A scientific team has discovered a genetic explanation for the higher incidence of kidney disease among African Americans. [Press release from Beth Israel Deaconess Medical Center discussing online prepublication in Science]

More Hope for Lab-Grown Lungs
Lung tissue grown in culture functioned for six hours when transplanted into living rats. [Press release from Nature discussing online prepublication in Nature Medicine]

Stem Cell Transplantation of Therapy-Resistant Chronic Leukemia Successful
Allogeneic stem cell transplantation offers the chance of cure for patients with an aggressive form of chronic lymphocytic leukemia, irrespective of genetic prognostic factors and the prior course of the disease. [Press release from EurekAlert! discussing online prepublication in Blood]

Gene Associated with Rare Adrenal Disorder Appears to Trigger Cell Death, According to NIH Study
A gene implicated in Carney complex appears to function as a molecular switch to limit cell growth and division. [Press release from the National Institutes of Health discussing online prepublication in PLoS Genetics]

Researchers Create Tumor-Fighting Immune Cells, Watch in Real Time as They Kill Cancer
Researchers at UCLA's Jonsson Comprehensive Cancer Center created a large, well-armed battalion of tumor-seeking immune system cells and used positron emission tomography (PET) to watch in real time as these special forces traveled throughout the body to locate and attack dangerous melanomas. [Press release from the University of California, Los Angeles discussing online prepublication in the Proceedings of the National Academy of Sciences USA]

Finding May Pave Way for New Treatments for Muscle Wasting Diseases
Researchers found that a protein produced by the muscle, TGF-beta2, helps motor nerves produce a big enough stimulus to trigger muscle contraction. [Press release from the University of Aberdeen discussing online prepublication in the Proceedings of the National Academy of Sciences USA]

Arsenic Shows Promise as Cancer Treatment, Study Finds
Combining arsenic with other therapies may give doctors a two-pronged approach to beating back forms of cancer caused by a malfunction in a critical cellular signaling cascade called the Hedgehog pathway. [Press release from the Stanford University School of Medicine discussing online prepublication in the Proceedings of the National Academy of Sciences USA]

Frosty Genes Can't Take the Heat
Researchers were successful in substituting cold-loving genes from Arctic bacteria for genes of warm-loving disease-carrying bacteria, meaning the pathogens can grow in the skin of mammals but not in warmer deep tissue. [Press release from the University of Victoria discussing online prepublication in the Proceedings of the National Academy of Sciences USA]

New Discovery in Nerve Regrowth
In addition to discovering for the first time that PTEN is found in the peripheral nervous system, researchers demonstrated that following nerve injury, PTEN prevents peripheral nerves from regenerating. Researchers were able to block PTEN, an approach that dramatically increased nerve outgrowth. [Press release from the University of Calgary School of Medicine discussing online prepublication in the Journal of Neuroscience]

Faulty Breast Cancer Gene Increases Male Risk Too
Western men who carry a BRCA2 genetic mutation have a six to nine per cent lifetime risk of developing breast cancer, UK researchers have found. [Press release from BioNews discussing online prepublication in the Journal of Medical Genetics]

Gene Find Offers Breast Cancer Hope
Researchers have identified the key role played by the gene c35 in causing the spread of HER2 positive breast cancer. [Press release from the University of Edinburgh discussing online prepublication in the British Journal of Cancer]

Bid to Aid Transplant Cancer Patients
Researchers have generated a bank of white blood cells from healthy blood donors to treat patients with a blood cancer called post transplant lymphoproliferative disease. The study found that patients treated with these blood cells remained free from the cancer for up to nine years following treatment. [Press release from the University of Edinburgh discussing online prepublication in Transplantation]

Gene Deletion Creates Lesbian Mice
Researchers found that disabling the fructose mutarotase gene in female mice causes them to avoid male advances and instead attempt to mate with other females. [Press release from BioNews discussing online prepublication in BMC Genetics]

Gene Therapy Breakthrough Heralds Treatment for Beta-Thalassemia
Italian scientists pioneering a new gene transfer treatment for the blood disorder beta-thalassemia have successfully completed preclinical trials, claiming they can correct the lack of beta-globin in patients' blood cells which causes the disease. [Press release from ScienceDaily discussing online prepublication in EMBO Molecular Medicine]

Stem Cells to Aid Study of Parkinson's
A new technique will use skin samples to grow the brain cells thought to be responsible for the onset of Parkinson’s disease, allowing these important neurons to be studied in detail. [Press release from Oxford University discussing research presented at the UK National Stem Cell Network Annual Meeting]

New Way to Discover Drugs That Aid Regenerative Medicine
Researchers have demonstrated how single stem cells can be encouraged to grow on finely-patterned surfaces in order to identify the biological messages that control their ability to divide and mature into any type of cell. [UK National Stem Cell Network Press Release]

Mexican Salamander Helps Uncover Mysteries of Stem Cells and Evolution
Researchers have found that there are extraordinary similarities in the development of Mexican aquatic salamanders and mammals that provide unique opportunities to study the properties of embryonic stem cells and germ cells. [UK National Stem Cell Network Press Release]

Mouse Stem Cell Study Offers New Insights into Body Fat Distribution
New research shows that adding fat to mouse stem cells grown in the lab affects their response to the signals that push them to develop into one or other of the main types of fat storage cells, subcutaneous or visceral. [UK National Stem Cell Network Press Release]

A New Generation of Biological Scaffolds
Researchers have been working on ways of producing biological scaffolds, derived from natural human or animal tissues that will not be rejected by a patient's immune system and can be repaired and renewed like normal tissue. The current technique removes the cells from natural tissues to leave a biological scaffold which can be regenerated by the patient's own cells. [Press release from the University of Leeds discussing research presented at the UK National Stem Cell Network Annual Meeting]

Four New Research Studies Describe Experimental Immunotherapies for Alzheimer's
Four new research studies reported at the Alzheimer's Association International Conference on Alzheimer's Disease 2010 describe experimental immunotherapies for Alzheimer's, two of which target tau directly and two of which may reduce tau even though their primary target was beta amyloid. [Alzheimer's Association International Conference on Alzheimer's Disease 2010 Press Release]

New Preimplantation Genetic Screening Method Can Predict Chromosomal Abnormalities, Study Shows
Researchers have shown that screening of polar bodies is a reliable method to analyze the chromosomal status of an egg. [Press release from ScienceDaily discussing research presented at the 26th Annual Meeting of the European Society of Human Reproduction and Embryology]

New Cell Therapy Treatment for Osteoarthritis to Be Trialed
Cultured stem cells are to be used for the first time in the UK to treat the common joint condition of osteoarthritis, throwing a potential lifeline to millions of sufferers in the future. [Keele University Press Release]

Largest Study of Genomes and Cancer Treatments Releases First Results
The largest study to correlate genetics with response to cancer drugs released its first results. The researchers behind the study describe in this initial dataset the responses of 350 cancer samples to 18 anticancer therapeutics. [Wellcome Trust Sanger Institute Press Release]

Artificial Blood Developed for the Battlefield
Scientists have made blood from hematopoietic stem cells from discarded human umbilical cords, which are turned into large quantities of red blood cells by a method called “blood pharming” that mimics the functions of bone marrow. [PhysOrg]

deCODE Discovers Genetic Risk Factor Linking Susceptibility to Four Major Vascular Diseases
Scientists at deCODE genetics and academic colleagues from the Netherlands and twelve other countries across Europe and North America report the discovery of a common single-letter variation in the sequence of the human genome conferring risk of a range of vascular diseases. [deCODE genetics Press Release]

Phase II Data From FIT Biotech’s HIV Immunotherapy Show Reduction in Viral Load and Increase in CD4 Cell Count
FIT Biotech announced results from a Phase II clinical trial. The company's immunomodulator FIT-06 showed unprecedented long-term reductions in viral load (approximately 0.5 log) and statistically significant CD4 cell count increases in HIV-infected, previously untreated patients. [FIT Biotech Press Release]

CURRENT PUBLICATIONS (Ranked by Impact Factor of the Journal)

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
Rituximab therapy was not inferior to daily cyclophosphamide treatment for induction of remission in severe antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis and may be superior in relapsing disease. [N Engl J Med]

Role of Tet Proteins in 5mc to 5hmc Conversion, Embryonic Stem Cell Self-Renewal and Inner Cell Mass Specification
The present studies not only uncover the enzymatic activity of the Tet proteins, but also demonstrate a role for Tet1 in embryonic stem cell maintenance and inner cell mass cell specification. [Nature]

Discovery of a Proneurogenic, Neuroprotective Chemical
Mice missing the gene encoding neuronal PAS domain protein 3 are devoid of hippocampal neurogenesis and display malformation and electrophysiological dysfunction of the dentate gyrus. [Cell]

Substrate Elasticity Regulates Skeletal Muscle Stem Cell Self-Renewal in Culture
Unlike muscle stem cells (MuSCs) on rigid plastic dishes, MuSCs cultured on soft hydrogel substrates that mimic the elasticity of muscle self-renew in vitro and contribute extensively to muscle regeneration when subsequently transplanted into mice and assayed histologically and quantitatively by noninvasive bioluminescence imaging. [Science]

Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
Researchers show that in African Americans, focal segmental glomerulosclerosis and hypertension-attributed end-stage kidney disease are associated with two independent sequence variants in the APOL1 gene on chromosome 22. [Science]

Regeneration and Orthotopic Transplantation of a Bioartificial Lung
After transplantation, lung constructs were perfused by the recipient's circulation and ventilated by means of the recipient's airway and respiratory muscles, and they provided gas exchange in vivo for up to 6 hours after extubation. [Nat Med]

Allogeneic Stem Cell Transplantation Provides Durable Disease Control in Poor-Risk Chronic Lymphocytic Leukemia: Long-Term Clinical and MRD Results of the GCLLSG CLL3X Trial
Allogeneic stem cell transplantation for poor-risk chronic lymphocytic leukemia can result in long-term minimal residual disease-negative survival in up to half of the patients independent of the underlying genomic risk profile. [Blood]

Cushing's Syndrome and Fetal Features Resurgence in Adrenal Cortex-Specific Prkar1a Knockout Mice
To demonstrate the implication of R1alpha loss in the initiation and development of primary pigmented nodular adrenocortical disease, researchers generated mice lacking Prkar1a specifically in the adrenal cortex (AdKO). AdKO mice develop pituitary-independent Cushing's syndrome with increased PKA activity. [PLoS Genetics]

Kinetic Phases of Distribution and Tumor Targeting by T Cell Receptor Engineered Lymphocytes Inducing Robust Antitumor Responses
Adoptive cell transfer of splenocytes from fully immunocompetent HLA-A2.1/Kbmice transduced with a chimeric murine/human T cell receptor specific for tyrosinase, together with lymphodepletion conditioning, dendritic cell-based vaccination, and high-dose interleukin-2, had profound antitumor activity against large established MHC- and antigen-matched tumors. [Proc Natl Acad Sci U S A]



Ireland Keeps Light Shining on Science with New Spending
In a surprise move, the Irish government (which is tottering on the brink of bankruptcy) announced that it would inject 359 million Euros into research. [Programme for Research in Third-Level Institutions, Ireland]

Russian Researchers Call for Better Coordination of Science
More than 2200 researchers sent an open letter to Russian President Dmitry Medvedev last week asking the government to set Russian science in order and to consult with the scientific community when making major science-policy decisions. [Russia]

“Game Over” for British Science?
The Royal Society and the British Academy strongly warned the British government that looming cuts to science funding could be “irreversibly catastrophic for the future of U.K. science and economic growth” if they go too far. [The Royal Society and the British Academy, United Kingdom]



Human Genome Sciences and Lonza Enter Commercial Manufacturing Agreement for Benlysta®, a Potential New Treatment for Systemic Lupus Erythematosus
Human Genome Sciences, Inc. and Lonza announced an agreement for the future commercial supply of BENLYSTA® (belimumab), which is currently under regulatory review in the United States and Europe as a potential new treatment for systemic lupus erythematosus. [Human Genome Sciences, Inc. Press Release]

Merck KGaA, Darmstadt, Germany Completes Millipore Acquisition and Launches New EMD Millipore Division (Merck Millipore Division outside U.S. and Canada)
Merck KGaA announced the successful completion of its acquisition of Millipore Corporation, a leading Life Science company based in Billerica, Massachusetts, U.S.A., for an aggregate purchase price including debt and cash of approximately $7.0 billion. [Millipore Corporation Press Release]

Eurofins MWG Operon and Genomatix Developed Most Complete Human Exome Array
Eurofins MWG Operon together with Genomatix Software GmbH announced that they have developed a complete human exome array, based on Roche NimbleGen sequence capture technology. [BioValley Press Release]

Midatech Group and Immunotope, Inc. Form Joint Venture, Syntara LLC, for the Development of Immune Therapies
Midatech Group Ltd. and Immunotope Inc. announced the formation of a joint venture Syntara LLC, to develop antigen based products for immune therapies to treat chronic viral infections and certain cancers. [FierceBiotech]

New Research Collaboration to Advance Stem Cell Use
North East-based Orla Protein Technologies Ltd., the UK Stem Cell Bank and Newcastle University, have been awarded a grant by the Technology Strategy Board to develop technology which could dramatically improve the way cells are grown in a laboratory. [UK Stem Cell Bank Press Release]

Kymab and Wellcome Trust Sign £20 Million Financing to Build a UK Biopharmaceutical Company Based on Human Monoclonal Antibody Technology from the Sanger Institute
Kymab and The Wellcome Trust investment division announced a £20 million Series A equity financing. [Kymab Limited Press Release]

Wilmot Obtains Nearly $2 Million in Cancer Stem Cell Funding
Two large federal grants received this summer will allow researchers at the James P. Wilmot Cancer Center to continue their work into stem cells that give rise to cancer. [University of Rochester Medical Center Press Release]

Emergent BioSolutions Awarded HHS Contract Valued at Up to $107 Million to Develop Large-Scale Manufacturing for BioThrax
Emergent BioSolutions Inc. announced that it has signed a contract valued at up to $107 million with the Office of the Biomedical Advanced Research and Development Authority of the Department of Health and Human Services (HHS), to develop and obtain regulatory approval for large-scale manufacturing of BioThrax® (Anthrax Vaccine Adsorbed) in Building 55. [Emergent BioSolutions Inc. Press Release]

Australia's Coridon Attracts Billionaire Investment
Andrew Forrest, billionaire CEO of the Australian mining company Fortescue Metals, has invested AU$3 million in the Ian Frazer-backed biotech company Coridon, which is developing DNA vaccines for a range of diseases. [FierceBiotech]

NIH Awards Rice $1.7 Million for Cartilage-Regeneration Research
Bioengineers from Rice University's BioScience Research Collaborative have won a $1.7 million grant from the National Institutes of Health (NIH) to develop an injectable mix of polymers and adult stem cells that can spur the growth of new cartilage in injured knees and other joints. [Rice University Press Release]

Lilly's Alzheimer's Gamble Aims at $10 Billion Patent Loss
With two Alzheimer’s drugs in the final stage of human testing and two more being developed behind them, Eli Lilly & Co. is committed to one of the riskiest bets in medicine to fill a potential $10 billion revenue gap. [Bloomberg]

Kinexus Cracks the Protein Kinase Specificity Code
Kinexus Bioinformatics Corporation announced major advancements in its PhosphoNET KnowledgeBase (www.phosphonet.ca) for the study of cell signaling systems. [Kinexus Bioinformatics Corporation Press Release]

FDA Grants Priority Review Designation to Denosumab Biologics License Application for the Reduction of Skeletal Related Events in Advanced Cancer Patients
Amgen announced that the U.S. Food and Drug Administration (FDA) has granted priority review designation to denosumab, a subcutaneous RANK Ligand inhibitor, for the treatment of bone metastases to reduce skeletal related events in patients with cancer. [Amgen Press Release]

Patent Is Filed on Shrink Nanotechnologies’ CellAlign Advanced Tissue Engineering Platform Technology
CellAlign has the potential to grow sheets of living tissues that may one day act as ‘band-aids’ to patch and repair, and possibly regenerate, damaged or diseased organs. [Shrink Nanotechnologies Press Release]

Aduro BioTech Announces Key Milestones in Advancing Its Leading Listeria-Based Immunotherapy Program
Aduro BioTech announced the issuance of two important patents, the formation of a distinguished scientific advisory board, the addition of key members to its Board of Directors, and the reporting of preliminary top line long term survival data from a Phase I clinical trial with 2 year follow up. [Aduro BioTech Press Release]


House Panel Approves 3.2% Raise for NIH in 2011
A House of Representatives spending panel yesterday approved a $1 billion increase, to $32 billion, in the 2011 budget for the National Institutes of Health (NIH).

NIH Expands National Network for Transforming Clinical and Translational Research
Nine health research centers have received funds to develop ways to reduce the time it takes for clinical research to become treatments for patients. The funds were awarded as part of the Clinical and Translational Science Awards program which is led by the National Center for Research Resources.

Harold Varmus Sworn in as National Cancer Institute’s 14th Director
Nobel Prize winner Harold E. Varmus, M.D., took the oath of office to become the National Cancer Institute’s 14th director.

Office of the Director; Notice of Establishment
Pursuant to the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), the Director, Office of Federal Advisory Committee Policy, National Institutes of Health, announces the establishment of the Interagency Pain Research Coordinating Committee.

Prospective Grant of Exclusive License: The Development of Human Therapeutics for the Treatment of Cancer

Pre-Application Meeting for Request for Applications (RFA-CA-10-016) for the Clinical Proteomic Technologies for Cancer Initiative (CPTC): Proteome Characterization Centers (NOT-CA-10-031)

Notice of Intent to Publish a Request for Applications for Tumor Microenvironment Network (TMEN) (NOT-CA-10-032)

Clarification of Additional Research Objectives for NICHD PAR-08-138, Genetic Screens to Enhance Zebrafish Research (R01) (NOT-HD-10-015)

Notice of Intent to Publish a Request for Applications on Lung Repair and Regeneration Consortium (U01) (NOT-HL-11-112)

NIMH Announces Availability of Funds for Competitive Revision Applications for a Repository Supporting Stem Cell Research Relevant to Mental Disorders (U24) (NOT-MH-10-024)

Notice of Expiration of Biomedical Technology Research Resource (PAR-08-259) and Reissuance of Biomedical Technology Research Center (P41)(PAR-10-225) (NOT-RR-10-011)

2011 NIH Directors New Innovator Award Program (DP2) (RFA-RM-10-009)



Charter of the Vaccines and Related Biological Products Advisory Committee

Currently Approved CBER NDAs/ANDAs

2010 Meeting Materials, Blood Products Advisory Committee

JFPS China-Clinical Trials International Summit 2010_645x110



FDA Weighs Rules for Consumer Genetic Tests
A high bar is likely to be set for companies seeking to sell genetic tests directly to consumers, according to top Food and Drug Administration officials. The agency is convening a two-day public hearing to discuss how it would regulate diagnostic tests, including direct-to-consumer tests.

International Conference on Harmonisation; Draft Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 14 on Bacterial Endotoxins Test General Chapter; Availability [Docket No. FDA-2010-D-0343]


Heads of Medicines Agencies Draft Strategy 2011-15 Consultation
The Heads of Medicines Agencies has launched a consultation on its draft strategy for the period 2011-2015.

EVENTS (Listed by Date)

2nd International Conference on Cellular and Molecular Bioengineering (ICCMB2)
August 2-4, 2010
Singapore City, Singapore

CHI's 5th Annual Immunotherapeutics and Vaccine Summit (ImVacS)
August 17-19, 2010
Cambridge, United States

Select Biosciences 3rd Annual Stem Cells Europe Conference
August 24-25, 2010
Edinburgh, Scotland

Select Biosciences 2nd Annual World Biobanking Summit
August 24-25, 2010
Edinburgh, Scotland

Select Biosciences Inaugural Cellular Therapy Summit
August 24-25, 2010
Edinburgh, Scotland

Viral Vectors in Gene Therapy: Applications and Novel Production Methods
August 26-September 4, 2010
Kuopio, Finland

Clinical Trials International Summit 2010
September 1-2, 2010
Shanghai, China

International Society for Cellular Therapy (ISCT) – Europe 2nd Regional Meeting
September 11-14, 2010
Belgirate, Italy

Hydra VI: The European Summer School on Stem Cells & Regenerative Medicine
September 11-17, 2010
Hydra, Greece

Joint Metastasis Research Society – American Association of Cancer Research Conference on Metastasis and the Tumor Microenvironment
September 12-15, 2010
Philadelphia, United States

Stem Cells USA & Regenerative Medicine Congress 2010
September 13-15, 2010
Philadelphia, United States

Select Biosciences 7th Annual RNAi & miRNA Europe
September 14-15, 2010
Dublin, Ireland

Select Biosciences Inaugural Epigenetics Europe Conference
September 14-15, 2010
Dublin, Ireland

Select Biosciences Inaugural Genomics Automation Europe Conference
September 14-15, 2010
Dublin, Ireland

Tissue Engineering & Regenerative Medicine International Society (TERMIS) – Asia Pacific 2010
September 15-17, 2010
Sydney, Australia

NEW Cellular Therapy of Cancer Symposium – ATTACK Project Meeting
September 24-27, 2010
Montpellier, France

International Society for Cell and Gene Therapy of Cancer (ISCGT) Congress
September 27-29, 2010
Doha, Qatar

4th American Association of Cancer Research International Conference on Molecular Diagnostics in Cancer Therapeutic Development
September 27-30, 2010
Denver, United States

Select Biosciences 6th Annual Ion Channel Targets Conference
September 28-29, 2010
Washington, DC, United States

Cytokines 2010: Cytokines in Infectious Diseases, Autoimmune Disorders and Cancer
October 3-7, 2010
Chicago, United States

2010 World Stem Cell Summit
October 4-6, 2010
Detroit, United States

5th World Congress on Preventive & Regenerative Medicine (WCRM)
October 5-7, 2010
Hannover, Germany

17th Annual Meeting German Society for Gene Therapy (DG-GT e.V.)
October 6-9, 2010
Munich, Germany

COGEM Symposium: GM Viruses as Medicine: Panacea or Pandora's Box?
October 7, 2010
Amsterdam, The Netherlands

American Association of Blood Banks (AABB) Annual Meeting & Cellular Therapy and Transfusion Medicine Expo (CTTXPO) 2010
October 9-12, 2010
Baltimore, United States

Translational Cancer Research for Basic Scientists
October 17-22, 2010
Boston, United States

European Society of Gene and Cell Therapy (ESGCT) 18th Annual Congress
October 22-25, 2010
Milan, Italy

3rd Annual Dubai Congress on Anti-Aging and Aesthetic Medicine (DCAAAM)
October 26-27, 2010
Dubai, United Arab Emirates

World Stem Cells & Regenerative Medicine Congress Asia 2010
October 26-29, 2010
Singapore City, Singapore

Select Biosciences 3rd Annual Molecular Diagnostics World Congress
October 28-29, 2010
San Diego, United States

Fraunhofer Life Science Symposium 2010
October 29-30, 2010
Leipzig, Germany

Stem Cell Society Singapore Symposium 2010: Translating Science to Therapy
November 2-3, 2010
Singapore City, Singapore

World Cord Blood Congress
November 4-7, 2010
Marseille, France

Select Biosciences 5th Annual European Biomarkers Summit
November 9-10, 2010
Florence, Italy

Select Biosciences International Forum on Stem Cells
November 12-13, 2010
Tianjin, China

Select Biosciences 2nd Annual RNAi Asia Conference
November 15-16, 2010
Singapore City, Singapore

9th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases
November 17-19, 2010
Sonoma, United States

Stem Cell Network 10th Annual Scientific Meeting
November 22-24, 2010
Calgary, Canada

Tissue Engineering & Regenerative Medicine International Society (TERMIS) – North America 2010 Annual Conference
December 5-8, 2010
Orlando, United States

Phacilitate 7th Annual Cell & Gene Therapy Forum 2011
January 24-26, 2011
Washington DC, United States

Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.



Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization's career opportunities with Cell Therapy News.
here to post your career opportunities.

Comments or Suggestions? Email [email protected] with your feedback.

 Learn more about Cell Therapy News:  Archives  |  Events  |  Update Profile  |  Contact Us